Restoring a Normal T Cell Receptor Repertoire Using the Xcellerate™ Technology: A Potential Therapeutic Strategy for Patients with Hematological Disorders and Autoimmune Diseases.

Alice Long, Mark Bonyhadi, Jahan S. Khalili et al.|Blood|2004

Cited by 0